Your session is about to expire
← Back to Search
Psychological Well-being Intervention for Healthcare Worker Burnout During COVID-19
N/A
Waitlist Available
Led By Charlesnika Evans, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up survey will be sent out at 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will assess the effectiveness of an online psychological well-being intervention (PARK) in reducing stress and associated-burnout, absenteeism, and intentions to leave the workforce in a subset of 750 persons who have been participating in a study of healthcare workers at Northwestern Medicine (NM) since Spring 2020.
Who is the study for?
This trial is for healthcare workers over 18 at Northwestern Medicine who are part of the NM HCW Serology Study and consent to participate. It includes pregnant women and all employees, except those no longer working at Northwestern Medicine.
What is being tested?
The PARK (Positive Affect Regulation sKills) online intervention is being tested to see if it can reduce stress, burnout, absenteeism, and intentions to leave among healthcare workers during the COVID-19 pandemic.
What are the potential side effects?
Since PARK is a psychological well-being intervention rather than a medical treatment, traditional side effects like with medication are not expected. However, participants may experience emotional discomfort or fatigue.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ survey will be sent out at 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~survey will be sent out at 3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Burnout
Burnout, Psychological
Psychological well-being
+1 moreSecondary study objectives
Cardiopulmonary Resuscitation
Cardiopulmonary Resuscitation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PARK NowExperimental Treatment1 Intervention
6-Week Self-Guided Program: PARK Positive Emotion Skills: The skills will be delivered over approximately 6 weeks, and individuals can participate from any device and location with internet access. A week will consist of 1-2 days of didactic material and 5-6 days of real-life skills practice and reporting. The maximum amount of time engaged in the PARK program for any participant is 5 hours over the 6-week period, plus completion of the REDCap surveys assessments (burnout, well-being, health behaviors). The intervention will focus on developing the following skills that will be supplemented by home practice: (1) positive events, capitalizing, gratitude; (2) mindfulness; (3) positive reappraisal; (4) personal strength and achievable goals; (5) and self-compassion.
PARK is delivered through the BrightOutcome online platform.
Group II: Wait List Control-PARK LaterActive Control1 Intervention
Wait list controls will be assessed at similar time intervals and will be offered PARK at end of follow-up.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,645 Previous Clinical Trials
958,039 Total Patients Enrolled
13 Trials studying COVID-19
71,457 Patients Enrolled for COVID-19
Charlesnika Evans, PhDPrincipal InvestigatorNorthwestern University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 18 and work at Northwestern Medicine.
Research Study Groups:
This trial has the following groups:- Group 1: PARK Now
- Group 2: Wait List Control-PARK Later
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger